Jahr Robert Charles 4
4 · Outlook Therapeutics, Inc. · Filed Jul 9, 2025
Insider Transaction Report
Form 4
Jahr Robert Charles
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-01+800,000→ 800,000 totalExercise: $1.58Exp: 2035-07-01→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on July 1, 2026, with the remaining shares vesting in 36 equal monthly installments over the following three (3) years, subject to the Reporting Person's Continuous Service to the Issuer through each such vesting date.